Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial
- 1 June 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 353 (9171) , 2195-2199
- https://doi.org/10.1016/s0140-6736(98)12291-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapyAIDS, 1999
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- HIV Treatment Failure: Testing for HIV Resistance in Clinical PracticeScience, 1998
- Multiple Concurrent Reverse Transcriptase and Protease Mutations and Multidrug Resistance of HIV-1 Isolates from Heavily Treated PatientsAnnals of Internal Medicine, 1998
- CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)The Lancet, 1998
- Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patientsAIDS, 1997
- Antiretroviral Therapy for HIV Infection in 1997JAMA, 1997
- Antiretroviral Therapy for HIV Infection in 1996JAMA, 1996
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995